0001144204-19-015117.txt : 20190320
0001144204-19-015117.hdr.sgml : 20190320
20190320160751
ACCESSION NUMBER: 0001144204-19-015117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180318
FILED AS OF DATE: 20190320
DATE AS OF CHANGE: 20190320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRZYBYL ARTHUR
CENTRAL INDEX KEY: 0001268135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 19694735
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
tv516671_form4.xml
FORM 4
X0306
4
2018-03-18
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001268135
PRZYBYL ARTHUR
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
1
1
0
0
President and CEO
Common Stock
2019-03-18
4
S
0
24802
63.53
D
205076
D
Common Stock
2019-03-19
4
S
0
2823
63.51
D
205076
D
Stock Options
33.00
2019-03-18
4
M
0
6375
0
D
2024-03-31
Common Stock
6375
0
D
Stock Options
40.59
2019-03-18
4
M
0
9375
0
D
2026-04-06
Common Stock
9375
18750
D
Stock Options
49.51
2019-03-18
4
M
0
9052
0
D
2027-03-30
Common Stock
9052
38448
D
Stock Options
49.51
2019-03-19
4
M
0
2823
0
D
2027-03-30
Common Stock
2823
35625
D
The shares were sold in multiple trades at prices ranging from $63.49 to $64.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
The shares were sold in multiple trades at prices ranging from $63.49 to $63.60. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
Option vests and are exercisable over a four year period beginning on the first anniversary of April 1, 2014.
Option vests and are exercisable over a four year period beginning on the first anniversary of April 7, 2016.
Option vests and are exercisable over a four year period beginning on the first anniversary of March 31, 2017.
/s/ Arthur Przybyl
2019-03-20